438 related articles for article (PubMed ID: 8820234)
21. Measles-mumps-rubella immunisation, autism and inflammatory bowel disease: update.
Amin J; Wong M
Commun Dis Intell; 1999 Aug; 23(8):222. PubMed ID: 10497836
[No Abstract] [Full Text] [Related]
22. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
[TBL] [Abstract][Full Text] [Related]
23. ACIP issues recommendations to eliminate measles, rubella and congenital rubella syndrome and to control mumps.
Rose VL
Am Fam Physician; 1998 Nov; 58(7):1682, 1685-6. PubMed ID: 9824963
[No Abstract] [Full Text] [Related]
24. [Thrombocytopenic purpura after isolated or combined vaccination against measles, mumps and rubella].
Autret E; Jonville-Béra AP; Galy-Eyraud C; Hessel L
Therapie; 1996; 51(6):677-80. PubMed ID: 9164004
[TBL] [Abstract][Full Text] [Related]
25. MMR vaccine is not linked to Crohn's disease or autism.
Commun Dis Rep CDR Wkly; 1998 Mar; 8(13):113. PubMed ID: 9592960
[No Abstract] [Full Text] [Related]
26. Measles immunization in HIV-infected children. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Pediatric AIDS.
Pediatrics; 1999 May; 103(5 Pt 1):1057-60. PubMed ID: 10224192
[TBL] [Abstract][Full Text] [Related]
27. Measles--Puerto Rico, 1993, and the measles elimination program.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1994 Mar; 43(9):171-3. PubMed ID: 8164642
[TBL] [Abstract][Full Text] [Related]
28. Lidocaine-prilocaine patch decreases the pain associated with the subcutaneous administration of measles-mumps-rubella vaccine but does not adversely affect the antibody response.
Halperin SA; McGrath P; Smith B; Houston T
J Pediatr; 2000 Jun; 136(6):789-94. PubMed ID: 10839878
[TBL] [Abstract][Full Text] [Related]
29. Measles, mumps, rubella vaccine administration in egg-sensitive children: systemic reactions during vaccine desensitization.
Trotter AC; Stone BD; Laszlo DJ; Georgitis JW
Ann Allergy; 1994 Jan; 72(1):25-8. PubMed ID: 8291745
[TBL] [Abstract][Full Text] [Related]
30. Measles, mumps, and rubella: prevention.
Booy R; Sengupta N; Bedford H; Elliman D
Clin Evid; 2006 Jun; (15):448-68. PubMed ID: 16973018
[No Abstract] [Full Text] [Related]
31. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
Salvadori P
Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974
[No Abstract] [Full Text] [Related]
32. Gender differences in the reactogenicity of measles-mumps-rubella vaccine.
Shohat T; Green MS; Nakar O; Ballin A; Duvdevani P; Cohen A; Shohat M
Isr Med Assoc J; 2000 Mar; 2(3):192-5. PubMed ID: 10774264
[TBL] [Abstract][Full Text] [Related]
33. Clinical safety issues of measles, mumps and rubella vaccines.
Afzal MA; Minor PD; Schild GC
Bull World Health Organ; 2000; 78(2):199-204. PubMed ID: 10743285
[TBL] [Abstract][Full Text] [Related]
34. Measles in Mexico, 1941-2001: interruption of endemic transmission and lessons learned.
Santos JI; Nakamura MA; Godoy MV; Kuri P; Lucas CA; Conyer RT
J Infect Dis; 2004 May; 189 Suppl 1():S243-50. PubMed ID: 15106118
[TBL] [Abstract][Full Text] [Related]
35. Rates of first measles-mumps-rubella immunisation in Wales (UK).
Thomas DR; Salmon RL; King J
Lancet; 1998 Jun; 351(9120):1927. PubMed ID: 9654262
[No Abstract] [Full Text] [Related]
36. MMR vaccination, Crohn's disease and autism: a real or imagined "stomach ache/headache?".
Passwell JH
Isr Med Assoc J; 1999 Nov; 1(3):176-7. PubMed ID: 10731330
[No Abstract] [Full Text] [Related]
37. The national measles and rubella campaign--one year on.
Commun Dis Rep CDR Wkly; 1995 Nov; 5(45):237. PubMed ID: 8541943
[No Abstract] [Full Text] [Related]
38. A measles epidemic controlled by immunisation.
Mansoor O; Blakely T; Baker M; Tobias M; Bloomfield A
N Z Med J; 1998 Dec; 111(1079):467-71. PubMed ID: 9972200
[TBL] [Abstract][Full Text] [Related]
39. Live virus vaccines in human immunodeficiency virus-infected children: a retrospective survey.
McLaughlin M; Thomas P; Onorato I; Rubinstein A; Oleske J; Nicholas S; Krasinski K; Guigli P; Orenstein W
Pediatrics; 1988 Aug; 82(2):229-33. PubMed ID: 3399296
[TBL] [Abstract][Full Text] [Related]
40. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance.
Pistol A; Hennessey K; Pitigoi D; Ion-Nedelcu N; Lupulescu E; Walls L; Bellini W; Strebel P
J Infect Dis; 2003 May; 187 Suppl 1():S217-22. PubMed ID: 12721916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
